Drug Eye Africa

Mozambique health minister calls for public-private investment in local health production

Health Minister Ussene Isse has invited national business and international partners to invest in local health technology production, speaking at the opening of the Mozambique Medical Expo 2026 in Maputo on 28 October.

The minister, representing President Daniel Chapo, described the event as a platform to catalyse change and bring together government, private sector and international partners. He said Mozambique wants to move from being “a mere spectator” in global health discussions to “an active and sovereign” participant in building structural and sustainable solutions.

Isse said strengthening medical and pharmaceutical assistance requires technological modernisation, rigorous quality and safety control of equipment and pharmaceutical products, and robust public-private partnerships. He called for greater synergy among all operators in the health ecosystem to respond swiftly, safely and effectively to clinical and epidemiological challenges.

During a tour of the exhibition, Isse was accompanied by Alberto Chambe, ANARME’s Executive Administrator for Operations and Research, and private sector representatives. The minister expressed satisfaction with the technological products on display for modernising the pharmaceutical sector.

The event’s inaugural panel addressed “Regulation of the Medicines and Medical Devices Market”, moderated by Professor Armindo Tiago. Cassiano Carlos João of ANARME presented on the global view and state of pharmaceutical regulation in Mozambique, highlighting the authority’s WHO Maturity Level 3 status and the importance of strict, risk-proportionate regulatory control through the integrated SIRMED system.

Lígia Mabunda of ANARME focused on post-market surveillance of medical devices and in vitro diagnostics, warning of the risks of under-reporting adverse events and stressing the need to optimise tecnovigilance and operational safety in health units through active, coordinated notification networks.

Private sector representatives Paulo Bagasse of SALUTEN and Mariamo Assane of APROMEM called for continuous improvement in ANARME’s operational implementation of regulations and joint legislative review to ensure greater openness and active participation in future regulatory consultation processes.

ANARME, a partner in organising the event, used its exhibition space to demonstrate practical tools transforming the regulated sector: a Track & Trace product tracking system to combat illicit circulation; the SIRMED digital portal for licensing and product registration; the ViGiMobile application for electronic reporting of adverse reactions and post-vaccination events; and mini-labs for medicine quality testing. The authority also issued pharmaceutical practice licences on-site and operated a dedicated counter for enquiries, complaints and suggestions.

Source: Autoridade Nacional Reguladora de Medicamentos (ANARME), “Sectores público e privado devem trazer soluções para desafios de saúde no país”, 30 October 2026: https://anarme.gov.mz/sectores-publico-e-privado-devem-trazer-solucoes-para-desafios-de-saude-no-pais/

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top